To most consumers, affordability is the most important health care problem we face as a nation.Reference Emanuel1 Health care unaffordability is largely the byproduct of high health care costs.Reference Jost2 In 2016, the United States spent $3.3 trillion on health care, or 17.9% of GDP.Reference Hartman3 Whether or not the country is spending “too much” on health care, most ordinary Americans viscerally understand that health care has become unaffordable, driven by rising health care costs. Middle class families spend 25% more on health care than they did a decade ago, and health care costs have risen faster than wages or inflation.Reference Gaynor4 An important threshold question is whose health care costs we are talking about. This essay defines “costs” as those costs that consumers must bear to obtain needed health care, which includes the individual and employer's share of health insurance premiums (because every dollar an employer spends on health care costs is offset by a reduction in wages)5 plus the consumer's out-of-pocket costs for cost-sharing or non-covered health care.Reference Claxton6
Following the election of President Trump and Republican majorities in both houses of Congress in 2016, political debate focused on repealing and replacing the Affordable Care Act (ACA), also known as Obamacare. The topline analysis of any Republican bill to repeal and replace the ACA centered on the proposal's impact on access — the number of people who would lose health coverage. And rightly so. The degree to which a health reform plan achieves universal and equitable access is a fundamental dimension on which to assess the worthiness of that plan.Reference Sage7 But it should also be clear how any new plan addresses health care costs and affordability, a primary concern for consumers and policymakers alike. To be sure, policies that reduce consumers' health care costs may also promote access and vice versa. Health care costs, access, and quality are interrelated — the famous “iron triangle” or “triple aim” of health policy — and policies targeting one issue will have spillover effects on the others.Reference Gostin8
Compared to coverage, it was more difficult to ascertain whether and how any of the GOP's health reform proposals would have controlled health care costs, particularly consumers' costs. The Congressional Budget Office (CBO) calculated the plans' budgetary impacts, but these figures do not tell ordinary consumers whether their own health care costs will rise or fall. The CBO also described the plans' effects on premiums and out-of-pocket spending, but these depended on which portion of the population was being measured — some individuals would see their premiums rise while others would see theirs fall or remain steady. Sometimes, reduced premiums were more than offset by increasing out-of-pocket costs. What has been lost in the details is a global assessment of the plan's theory of cost control.
This essay provides a framework to assess health reform plans on their theories of cost control and applies the framework to ACA and the Republican's 2017 legislative efforts to repeal and replace the ACA. The framework identifies the key policy tools to constrain health care costs organized in a two-by-two matrix across the following dimensions: price vs. utilization and public vs. private payers. The framework can be used to assess any plan of health care reform to reveal its general theory of health care cost control. Identifying a health reform plan's theory of cost control allows policymakers and voters to assess how it aims to control rising health care costs, just as we track the plan's coverage effects.
To most consumers, affordability is the most important health care problem we face as a nation. Health care unaffordability is largely the byproduct of high health care costs. In 2016, the United States spent $3.3 trillion on health care, or 17.9% of GDP. Whether or not the country is spending “too much” on health care, most ordinary Americans viscerally understand that health care has become unaffordable, driven by rising health care costs. Middle class families spend 25% more on health care than they did a decade ago, and health care costs have risen faster than wages or inflation.
The ACA's theory of cost control focused primarily on constraining utilization and payment rates in the Medicare program, with some utilization controls for the private market. It has been modestly successful, and its initial limitations were due to its lack of policies to control private health care prices, and later by Trump administration actions to undermine the ACA's cost control policies. By comparison, the GOP's plans' stated theory of cost control was to dramatically reduce federal health care spending, reduce regulation, and increase state flexibility to create incentives for cheaper health care. But in many instances, these policies would have raised most consumers' health care costs and did not address the key drivers of rising health care costs: prices or utilization.
This essay proceeds in three parts. Part I sets forth a framework for evaluating a health reform plan's theory of cost control. Part II applies the framework to assess the theories of cost control in the ACA and the GOP's 2017 replacement plans. Part III discusses the importance of assessing health reforms for their theory of cost control as well as the framework's limitations.
I. Theories of Health Care Cost Control — The Framework
As with all goods and services, health care costs are a function of utilization and price: how many items or services you consume multiplied by the price of each item.Reference Emanuel9 But unlike other consumer goods and services, most people purchase health care with third-party insurance, so the “price” they focus on is their insurance premium or deductible, not the unit price of a given procedure. Third-party payment obscures the underlying prices, but a consumer's health care premiums and out-of-pocket costs are still driven primarily by the simple function of price times quantity. Thus, policies that seek to control health care costs must also target these two key variables. The policies may target public or private payers. The reason to separate public from private payers is that the federal government has somewhat different policy options for each, with greater authority to regulate Medicare and Medicaid directly and a greater reliance on free markets and state authority to regulate private insurance markets. Looking at a health reform vehicle as a whole, you can discern its theory of cost control by assessing its mechanisms to address the price and utilization components of health care costs across public and private payers.
A. Policies to Control Overutilization
Utilization describes the quantity and resource-intensity of health care consumed. Overutilization contributes to excess health care costs when health care services are wasteful, duplicative, more intensive, or furnished in a more expensive setting than necessary. Overutilization in health care is largely driven by physician-induced demand, in which physicians have financial incentives to order more services and more intensive services.Reference Johnson and Culyer10 Overutilization can also result from health system fragmentation, which can lead to duplicative services and delays from providers' lack of coordination. To a lesser extent, overutilization is also driven by moral hazard, the tendency to consume more services when it is financed by a third party than you would if you had to bear the full cost of your consumption.Reference Pauly11 The tax break employers receive on employee health benefits exacerbates moral hazard by allowing employees to purchase more insurance than they would with after-tax dollars.Reference Pauly12
Policies to control overutilization target physician-induced demand, fragmentation, and moral hazard. Physician-induced demand and fragmentation are curbed through payment and delivery reforms that change the way services are reimbursed. Payment and delivery reforms entail moving from fee-for-service to risk-based payment such as capitation, accountable care organizations (ACOs), or bundled episode-based payments, which all shift financial risk from the insurer to providers for the efficiency and value of the care they provide.Reference Rosenthal13
In addition, overutilization in Medicare and Medicaid is policed through fraud and abuse laws that penalize not just outright fraud, but also incentives for physician-induced demand from financial relationships among physicians and providers.14
One solution to moral hazard is patient cost-sharing in the form of deductibles, co-payments, and co-insurance.Reference Newhouse15 Exposing consumers to some of the cost of consumption at the point of service sensitizes the consumer to costs and reduces moral hazard. In addition, changes to the preferred tax treatment of employer-based health coverage can also reduce moral hazard.
Policies to control overutilization in public programs typically focus on payment reforms and fraud and abuse enforcement, while policies for overutilization in private markets focus on patient cost-sharing, tax policy for employer-based insurance, as well as payment changes.
B. Policies to Control Prices
The prices of health care goods and services, regardless of how they are paid for, are driven by an array of variables, including the costs of labor, overhead, market power, administrative costs, and technology. In government health care programs, prices paid to providers are set administratively. To constrain Medicare spending, Congress may change how Medicare pays providers and suppliers. Although altering Medicare payment rates is politically contentious due to the lobbying power of hospitals and physicians, Congress has periodically altered Medicare payment rates and methods to constrain Medicare spending growth.
In the private market, there are three policies to control prices: (1) encourage competition and market forces to discipline prices; (2) enforce antitrust laws to prevent anticompetitive behavior and combinations; and (3) regulate monopolistic sellers' rates. In a competitive market, policies can encourage market forces by improving the transparency and comparability of prices and products. Because health insurers and employers typically purchase health care for their enrollees, network management strategies such as tiered or narrow networks can be used to steer consumers to lower-cost, higher-value providers and suppliers.Reference White16
The U.S. health care market is not perfectly or even mostly competitive because of widespread consolidation and barriers to entry.17 In noncompetitive health care markets, prices are high and rising primarily because of increasing concentration of market power in dominant providers and suppliers.Reference White18 Without competition, market forces cannot discipline prices, and policymakers are left with two options: antitrust enforcement and rate regulation. Antitrust enforcement seeks to protect competition by preventing anticompetitive mergers and behavior, but it is generally ineffective at restoring competition or preventing existing monopolies from exercising their market power.Reference Havighurst and Richman19
In consolidated health care markets, the last remaining policy option is rate regulation, in which the government administratively limits or sets health care prices, similar to a public utility.Reference Berenson20 The best-known example is Maryland's all-payer rate setting system, where an administrative body sets hospital rates like a utility.Reference Frankford and Rosenbaum21 However, constraining prices can cause providers to make up revenue by increasing volume, so rate setting must be paired with strategies to limit overutilization such as global budgets or ACOs.Reference Murray22 All-payer rate setting is politically and technically difficult, but less-intensive rate regulation options could discipline private prices, including capping private provider prices, global budgets for providers, or a public option, such as allowing anyone to buy Medicaid coverage.Reference Brown23
C. The Framework
If you plot the factors of price/utilization and public/private markets against each other, it forms a 2x2 matrix for identifying policies to control health care costs. Using this matrix of policy tools as a checklist can reveal a health reform plan's theory of cost control as well as its policy gaps. The framework is set forth in Figure 1:
Framework of Assessing Health Care Cost Control Policies

II. The Theories of Cost Control in Health Reform
A. The ACA's Theory of Cost Control
The ACA had a fairly comprehensive approach to control the twin drivers of health care costs: it cut Medicare payment rates significantly and attacked overutilization in Medicare and private markets.Reference Brown24 But the ACA had few strategies to control rising prices in the private market, leaving to states the primary responsibility of pursuing policies to control prices.
1. QUADRANT A — MEDICARE UTILIZATION
The ACA's policies to control utilization in Medicare focused primarily on altering Medicare payment models to providers to reduce overutilization and waste. Because Medicare sets prices for services administratively, reducing overutilization plays an outsized role in cost-containment. The ACA's focus on utilization was also shaped by Atul Gawande's influential New Yorker article, “The Cost Conundrum,” which convinced the drafters of the ACA that nearly a third of Medicare spending could be cut without affecting quality or outcomes by reducing overutilization and waste.Reference Gawande25 The resulting policies were the ACA's Medicare payment reforms to encourage fragmented providers to work together and coordinate care to improve quality and efficiency, including establishment of Medicare ACOs and bundled payments, which reward groups of providers by paying them a share of the money they save Medicare or paying a lump sum for a patient's entire episode of care.Reference Cutler26
The ACA also refined federal fraud and abuse laws as part of a larger push for greater federal enforcement of health care fraud and abuse laws under the Obama administration.
2. QUADRANT B — UTILIZATION IN THE PRIVATE MARKET
The ACA contained two main strategies to curb over-utilization in the private market: supply-side payment reforms and demand-side tools to increase consumerism among patients. On the supply-side, many of the payment reforms implemented in Medicare were adopted by private payers, such as ACOs and other risk-based arrangements to reduce provider-driven overutilization. By 2017, over 900 ACOs had formed, covering more than 32 million people, or over 10% of the population.Reference Muelstein27 Nearly 60% of the ACO contracts and “covered lives” were with private payers, with Medicare and Medicaid making up the rest.28 Although the ACA did not direct the creation of private ACOs, the incentives and regulatory glide-path created for Medicare ACOs sped the adoption of these models among private payers.Reference Greaney29
The second strategy to control utilization in the private market focused on sensitizing patients to the costs of health care consumption and reducing demand through increased cost-sharing. Although high-deductible health plans with high levels of cost-sharing preceded the ACA, the plans sold on the ACA marketplaces continued this trend and generally featured fairly high rates of patient cost-sharing. To dampen the adverse effects of cost-sharing on lower-income individuals, the ACA implemented cost-sharing reductions for individuals whose household income falls between 100-250% of the federal poverty level and who purchase silver plans on the marketplace.30
For employer-based coverage, the ACA contained a provision known as the “Cadillac tax” on high-cost employer-based plans, which was designed to reduce health care spending by increasing employees' share of those costs.31 Currently, employee compensation paid in the form of health benefits are not subject to payroll or income taxes, which skews incentives toward paying employees in health benefits rather than in taxable wages. Having too much health insurance creates moral hazard, which drives up utilization and health care costs. To correct for the inefficiency created by moral hazard and excessively generous insurance, the Cadillac Tax imposes a 40% excise tax on health coverage that costs in excess of $29,000 for family coverage, $10,700 for individual coverage.Reference Furman, Fiedler, Mankiw and Summers32 The Cadillac Tax is unpopular particularly among unions and employee groups subject to the tax, but also because its indexing formula will apply the tax to a broader swath of less-generous health benefits over time.Reference Lemieux and Moutray33 As a result, Congress has twice delayed implementation of the Cadillac Tax, first from 2018 to 2020,34 and then until 2022.35
3. QUADRANT C — MEDICARE PRICES
Unlike private health care prices, which are established through negotiation between providers and health plans, provider prices in public programs are administratively set. The ACA's primary policy to constrain public prices took the form of significant cuts to Medicare reimbursement rates — $716 billion over 10 years — particularly for hospitals and Medicare Advantage plans.Reference Kliff36 The ACA imposed a variety of hospital payment cuts, such as cuts to disproportionate share payments, and also cut rates to the private managed care plans that serve Medicare beneficiaries to levels closer to amounts spent on beneficiaries in “traditional” Medicare.
The ACA also created the Independent Payment Advisory Board (IPAB), an agency that would prescribe Medicare payment cuts that would automatically go into effect to constrain Medicare spending growth to the rate of GDP growth plus one percent.37 Because of IPAB's statutory constraints and Congress' long struggle to hem in Medicare's physician payments, many believed IPAB would rely on physician payment cuts to reduce Medicare spending.Reference Marciarille and DeLong38 Since the ACA was enacted, however, Medicare's projected growth never exceeded the threshold for IPAB to take action, and the Board was never constituted before being repealed in 2018.Reference Cunningham39 Despite political opposition, IPAB was designed as a safety valve to constrain Medicare spending through provider payment cuts, circumventing the political pressure members of Congress face from powerful provider groups that can prevent Medicare rate cuts from going into effect.Reference Ho40
4. QUADRANT D — PRIVATE PRICES
Applying the cost control framework to the ACA reveals it lacks comprehensive policies to control private health care prices. In short, the ACA has a blind spot in quadrant D.41 As mentioned above, there are three policy options to control private health care prices: market solutions that focus on consumerism and price competition, antitrust enforcement, and rate regulation. Of these three price control strategies, the ACA favored market solutions.
The ACA's market-based strategies included increasing transparency of hospital charges, promoting competition among plans on the marketplaces, and narrowing provider networks for marketplace plans.Reference Ginsburg and Pawlson42 Narrow provider networks are the key strategy to constrain premiums when medical underwriting is prohibited.Reference Dafny43 But market approaches only work when there are choices among providers or plans, and the ACA contained few policies to address rising prices in noncompetitive markets. The ACA weakened antitrust scrutiny for Medicare ACOs, which have driven much of the recent industry consolidation.44 Antitrust can do little to restore competition or constrain price growth once consolidation has occurred. On rate regulation, the ACA did little beyond encouraging states to test rate setting models. Overall, the ACA had few policies to control private prices and may have inadvertently spurred further consolidation through its emphasis on risk-based payment and ACOs.
An earlier version of the bill that became the ACA contained a more robust price control strategy: the public option.Reference Berenson45 A public option could have allowed a publicly operated health plan to compete with commercial plans on the marketplaces, importing public payers' administrative price controls into the marketplaces for individual and small group plans. In light of current marketplace instability, rising premiums, and insurer exit caused by the Trump administration's disruptions, a public option may have been the only option remaining in many regions that struggle to retain even a single health plan in the marketplace. The public option was ultimately eliminated from the ACA, but states have begun to explore their own public options.Reference Hervey46
5. ASSESSING ACA's THEORY OF COST CONTROL
Without a unified measure of consumers' health care costs, it is difficult to pinpoint the effect of the ACA's cost control policies. On broader measures of health spending, the ACA appears to have been somewhat successful. The overall rate of health care spending growth moderated in the years following the ACA, though much of this effect may be due to the economic recession.Reference Holahan47 Medicare spending growth was also slower than average, growing only 1.3% annually between 2010 to 2016, down from 7.4% annually from 2000 to 2010, in part due to the ACA's Medicare payment cuts and reforms.Reference Cubanski and Neuman48 But the evidence is mixed whether ACOs can reliably generate savings from reduced utilization and improved efficiency.Reference Lewis49 What is clear is that health care costs cannot be constrained on utilization alone.Reference Papanicolas50 In the private market, premium growth has been moderate, but it has been offset by rapidly increasing deductibles and out-of-pocket costs.Reference Hancock and Luthra51 Private health care prices have also been rising, particularly for outpatient services and prescription drugs, while utilization growth has been low.52 And there is little evidence of improvement to high administrative costs, driven by the complexity of a fragmented health care payer landscape.Reference Tseng53
The ACA also contained policies promoting health care affordability — the Medicaid expansion, premium and cost-sharing subsidies for marketplace plans, and cost-sharing limits — even if these policies did little to constrain underlying health care costs. These provisions limit the amount lower-income and sicker individuals spend on health care, but they do not curtail the price or quantity of health care services provided. In this regard, these ACA affordability provisions are better characterized as policies to promote health care access than to control health care costs.
B. The Theory of Cost Control in the 2017 ACA Replacements
Of the GOP's various legislative attempts to repeal and replace the ACA in 2017, the most significant were three budget reconciliation measures taken up in the House and Senate: the American Health Care Act (AHCA),54 which passed the House on May 4, 2017; the Senate's Better Care Reconciliation Act (BCRA),55 which failed to pass the Senate in July; and the amendment to the AHCA proposed by Senators Lindsey Graham, Bill Cassidy, and others in September (“Graham-Cassidy”).56 In addition, the Tax Cuts and Jobs Act of 2017 eliminated the ACA's individual mandate penalty, effective January 1, 2019.Reference Jost57 All but the Tax Cut and Jobs Act failed to pass. According to proponents, the GOP's theory of cost control was that federal deregulation and spending cuts plus greater state flexibility and individual responsibility in the form of greater cost-sharing would unleash market forces and spur innovation and competition to make health care more affordable. Applying the framework above, however, reveals that the GOP's plans to repeal and replace the ACA lacked a coherent theory of cost control.
1. QUADRANT A — UTILIZATION IN MEDICARE/MEDICAID
None of the Republicans' proposals would have altered the Medicare payment and delivery reforms of the ACA. In particular, no changes were proposed for Medicare ACOs, and the Trump administration has largely maintained the bundled-payment program.Reference Pear58
Nor has Congress or the Trump administration made significant changes to Obama-era fraud and abuse enforcement laws or policy, proposing increased budgets for enforcement of health care fraud and abuse.Reference Sweeney59 With annual recoveries for federal health care programs typically topping $2 billion,60 bipartisan support continues for aggressive fraud and abuse enforcement for federal health care programs.
2. QUADRANT B — UTILIZATION IN PRIVATE MARKETS
The GOP proposals' main policies to curtail overutilization in the private markets were to increase consumers' financial “skin in the game” through increased reliance upon health savings accounts (HSAs) and high-deductible health plans. All three bills would have increased the tax-free annual contribution limits to HSAs, and the BCRA and Graham-Cassidy would have allowed individuals to use HSA funds to pay for premiums.61 These represent a change in degree rather than in-kind from existing law, under which tax-preferred HSAs are permitted for enrollees in high-deductible health plans.62 High deductibles are a demand-side policy tool to reduce utilization driven by moral hazard. The increased tax-free contribution limits would further encourage high-deductible plans and primarily benefit high-income individuals, who are more likely to contribute to such accounts and benefit from the tax break.Reference Levey and Kim63
Other changes in the Republican proposals would have increased consumers' out-of-pocket costs, particularly in the non-group market.Reference Altman64 First, reducing the required actuarial value of plans sold on the marketplaces would mean more plans would have higher cost-sharing.65 Second, reducing or allowing states to waive the essential health benefits that plans must cover would increase costs for those who need non-covered benefits.66 Third, allowing states to waive annual cost-sharing limits would mean that cost-sharing levels would rise or become uncapped.Reference Fiedler67 Fourth, the termination of the ACA's cost-sharing reduction payments for those earning between 100-250% of the federal poverty level would expose low-income marketplace enrollees to higher cost-sharing amounts.68
Although increasing consumer cost-sharing reduces moral hazard, it does not get at the larger driver of overutilization — the financial incentives for physicians to induce demand for health care services.Reference Nyman69 Even modest cost-sharing dampens the utilization effects of moral hazard, yet patients tend to cut back on necessary as well as unnecessary care.70 Increasing cost-sharing disproportionately burdens the poor and those with chronic illnessesReference Fung71 and also reduces afford-ability. When ordinary people hear policymakers promise that health care will be more affordable, most people believe their premiums and out-of-pocket costs will go down. The bills to repeal and replace the ACA would have done the opposite.
3. QUADRANT C — MEDICARE/MEDICAID PRICES
The Republican proposals did not alter the ACA's various Medicare provisions, including its provider rate cuts.72 However, Republicans repealed the ACA's Independent Payment Advisory Board (IPAB) in February 2018 in a wide-ranging budget deal.73 Although it is unclear whether IPAB would ever have been allowed to take action, the CBO estimated that repealing IPAB will cost the government $17.5 billion over a decade, because it will eliminate a mechanism to curtail Medicare spending growth over time.74
More significantly, the GOP's 2017 bills proposed momentous changes to the Medicaid program in the form of massive federal spending cuts and substantive program alterations.Reference Rosenbaum75 The AHCA would have cut federal Medicaid spending $834 billion over a decade.76 The BCRA would have cut Medicaid by $772 billion, Graham-Cassidy by $1 trillion.77 All the bills would have reduced or eliminated enhanced federal funding for the Medicaid expansion and converted federal Medicaid financing to a per capita cap or block grant, effectively moving the federal government's Medicaid funding from an open-ended obligation to a limited budget.78 Other substantive changes to the Medicaid program, such as allowing states to impose work requirements on Medicaid beneficiaries, have subsequently been adopted administratively by the Trump administration.79
The GOP's proposed Medicaid cuts were not aimed at reducing consumers' health care costs; they were designed to pay for repealing the ACA's tax on high-income earners.Reference Prokop80 Proponents argued that capping federal Medicaid spending and imposing work requirements would encourage enrollees to seek private coverage through employment and reduce taxpayer spending on Medicaid. But shifting individuals from Medicaid, with little or no premiums or cost-sharing, to private coverage would increase those individuals' health care costs. The primary effect of the Medicaid cuts would have been to reduce Medicaid enrollment by about 15 million people over the ensuing decade.81 Federal Medicaid cuts of this magnitude could lead to cuts in provider reimbursements under state Medicaid programs, but more likely would result in reductions in benefits and eligibility. Noting that Medicaid is already a poor payer, the CBO predicted that Medicaid cuts could reduce access and quality as providers drop out or curtail services to Medicaid beneficiaries.82 Even conservative analysts noted that the Medicaid cuts made little sense as a cost-disciplinary measure within the framework of GOP health reforms.Reference Ippolito83 The Republicans' proposed Medicaid cuts were not designed to control health care costs, particularly when costs are measured from the point of view of consumer affordability; their raison d’être was to pay for the bills' tax cuts.
4. QUADRANT D — PRIVATE PRICES
The GOP's primary strategy to constrain private health care prices was to improve competitive market forces, largely in terms of health insurance premiums in the non-group market. To Trumpcare's proponents, the main driver of high health insurance premiums were burdensome Obamacare insurance regulations (e.g., requiring community rating and essential health benefits).Reference Stein84 Allowing states to waive the ACA's insurance regulations would allow for cheaper, skimpier, and more “actuarially fair” plans to be sold on the non-group market.Reference Sperling and Shapiro85 Two problems arise with this strategy to control health care costs. At the macro-level, average premium costs are driven less by actuarial rules than by rising health care prices, and like Obamacare, the Trumpcare proposals did little to address the underlying prices of health care items and services. At the micro-level, the GOP proposals would only make health insurance more affordable for the young and healthy, and predominantly males, while increasing premiums for everyone else.Reference Sanger-Katz86 The Republican plans contained funding for states to subsidize health insurance costs for sicker individuals through high-risk pools or risk-adjustment, but many believed this funding was inadequate to make up for the higher premiums these individuals would face.Reference Jost87 Eliminating the individual mandate penalty, the only ACA provision that the GOP was able to effectively repeal in 2017, will raise premiums in the marketplaces by about 10% as healthier people drop coverage.88 In other words, it was at best a half-truth that the GOP's plans would make premiums cheaper, which undermines its primary theory of cost control.
5. ASSESSING THE GOPS PLANS' THEORY OF COST CONTROL
Without comprehensive policies aimed at controlling health care costs, the Republican plans lacked a general theory of cost control. To be sure, proponents of the GOP's health reform bills did not really tout them as a vehicle to reduce health care costs. The exception was President Trump, who tweeted the day that AHCA passed the House, “Insurance companies are fleeing ObamaCare — it is dead. Our healthcare plan will lower premiums & deductibles — and be great healthcare!”Reference Trump89
Health policy analysts, even conservative ones, attacked the ACA replacement proposals for lacking an effective plan to control costs.90 A common conservative critique was that the GOP's bills would not restore or strengthen the ACA's Cadillac tax on high-cost, employer-based health plans and failed to curtail the tax-exclusion of employer-based health coverage, which they argued leads to inefficient care and dampens consumers' cost-sensitivity.Reference Capretta91 Contrary to these economic arguments, in early 2018 the Republican-controlled Congress passed a measure to further delay the implementation of the Cadillac Tax until 2022.92
In broadest strokes, the GOP's collective legislative and administrative attempts to repeal and replace the ACA in 2017 sought to restore the U.S. health care market to a pre-ACA state. The theory's flaw is that the pre-ACA market to which the GOP would have returned us had runaway health care cost inflation. Returning to a pre-ACA state would not solve the rampant market imperfections that prevented competitive forces from disciplining health care spending and costs in that era.
In broadest strokes, the GOP's collective legislative and administrative attempts to repeal and replace the ACA in 2017 sought to restore the U.S. health care market to a pre-ACA state. The theory's flaw is that the pre-ACA market to which the GOP would have returned us had runaway health care cost inflation. Returning to a pre-ACA state would not solve the rampant market imperfections that prevented competitive forces from disciplining health care spending and costs in that era.
III. Discussion
Applying the cost control framework to the ACA and the GOP's ACA replacements reveals their inner scaffolding and their framers' vision for a more optimal health system. The ACA's cost controls were premised on a Medicare-centric approach that focused on a utilization-oriented narrative of eliminating fragmentation, waste, and inefficiency. The ACA's theory of cost control had a blind spot — it lacked robust policies to control health care prices in the private health care market and may have inadvertently driven providers to consolidate to adapt to the payment and delivery reforms designed to curb overutilization.
The GOP's various efforts to repeal and replace the ACA in 2017 lacked a coherent theory of cost control because its policies would have raised most consumers' health care costs. To the extent proponents made a cost control argument, it was that increased state flexibility and reduced regulation would lead to innovation and cost-savings, particularly in the form of reduced premiums. Commenting on Graham-Cassidy, Senator Jim Inhofe (R-OK) stated, “[I] t's more efficient when it's done from the states, and so they can do it with less money,” and Senator Ted Cruz (R-TX) said, “The biggest reason so many millions of people are hurting under Obamacare is that it has made premiums skyrocket. And what I think is critical for Obamacare repeal is that we expand consumer freedom so that you, the consumer, can be in charge of what health insurance you want to buy, and we lower premiums so that health insurance is more affordable.”93
The rhetoric of health care cost-containment is slippery. First, it is important to be clear whose costs are being reduced. Reducing federal government health care spending may be a reasonable policy objective, but some policies to reduce federal spending shift more costs to individuals, raising their premiums and outof-pocket expenses. Moreover, anchoring the bill's cost-control mechanisms to notions of state flexibility or consumer choice does not answer how the proposal will address the twin drivers of health care costs: over-utilization and sky-high prices. To the extent the GOP plans sought to reduce premiums, they were solving a problem of their own making when they undermined the functioning of the ACA marketplaces.
The framework to characterize the theory of cost control for health reform proposals has some limitations. First, the framework does not itself measure the policies' effects on an average person's expected health spending, per capita health spending, or any other index of health care costs.Reference Emanuel94 Second, it is necessarily descriptive rather than prescriptive. It does not tell us what policies legislators ought to pursue or even if those specific policies are likely to be successful. Third, a health reform proposal's theory of cost control cannot be crisply separated from its theories of access or quality because in reality the phenomena are interrelated. Health care costs are themselves a barrier to access.Reference Cox and Sawyer95 Policies to improve affordability, such as subsidies or Medicaid expansion, may improve access rather than control systemic drivers of health care costs. Moreover, questions of distributive justice arise when costs rise disproportionately for the poorer and sicker members of the population, but are reduced for the healthy and wealthy, as the GOP's ACA replacement plans would have done.
Nevertheless, identifying a theory of cost control helps policymakers and voters assess whether the health reform vehicle attempts to control costs, and whether the plan has a comprehensive strategy or a blind spot. Given the importance of health care afford-ability to consumers, a framework to identify a proposal's cost controlling policies is needed to evaluate whether legislators' vague promises to make health care more affordable actually translate into policies to do so. Just as we assess the coverage impacts of a particular reform proposal, proponents should also be forced to answer how the plan will constrain health care costs. Failing to account for costs ignores consumers' most pressing health care concerns and obfuscates the real economic, distributional, and pocketbook effects of the health reform vehicle. Without a strategy to deal with rising prices and overutilization, no health reform will durably succeed in bending the health care cost curve.
Acknowledgements
The author acknowledges Lindsay Wiley, the American University Washington College of Law, and the American Society of Law, Medicine & Ethics for hosting and sponsoring the Next Steps in Health Reform Conference in October 2017 from which this volume of JLME is drawn. Thank you to Jaime S. King and Timothy Lytton for their insightful and helpful comments and Min Ji Kim for her excellent research assistance.

